| ISRAEL | |||||||||
| Last update | 2007-05 | 2007-05 | 2010-02 | 2007-05 | |||||
| Company | Bio-Products Laboratory | Biotest Pharma GmbH | CSL-Behring | Grifols | |||||
| Name of product | Vigam | Intraglobin® F | Sandoglobulin (lyo) | Flebogamma | |||||
| Available for Hospital therapy | Yes | Yes | Registered | Yes | |||||
| Available for Home therapy | - | not available for home therapy | - | ||||||
| IVIG, SCIG or IMIG | IVIG | IVIG | IVIG | IVIG | |||||
| Patient´s age | Adults and pediatrics | unlimited | Adults and children | ||||||
| Présentation | Liquid | ready-to-use solution | Lyophilisat | Liquid | |||||
| Concentration % | 5% | 5% solution | 3%, 6%, 9%, 12% | 5% | |||||
| Content of IgG | 95% | ≥ 95% | ≥ 96% | ≥ 99% | |||||
| IgG1 | 65 | 62% | 60.7% | 70.3% | |||||
| IgG2 | 29 | 34% | 31.9% | 24.7% | |||||
| IgG3 | 6 | 0.5% | 3.8% | 3.1% | |||||
| IgG4 | 1 | 3.5% | 3.6% | 2% | |||||
| Content of IgA | < 0.02% w/w | ≤ 2.5 mg/ml | 1.2g/L (typical value) | <0,05 mg/ml | |||||
| Glucose, Maltose,… | Sucrose | glucose 25 mg | Sucrose | ||||||
| Average dosage for PID | Dependant on age and weight of patient | initial 0.4 - 0.8 g/kg, followed by 0.2 -0.8 g/kg | 0.2-0.8g/kg bodyweight | ||||||
| Max. Speed of infusion | 3 ml/minute | 2.2 mg/ml per hour | About 2.5ml/min | ||||||
| Intervals of infusion for PID | Every 2-4 weeks to obtain IgG trough level of at least 4-6 g/L | dependent on the individual serum IgG level between 2 and 4 weeks | Usually every 2-4 weeks | ||||||
| Preserving | Vigam® Liquid should be stored in the dark in its carton, between 2° and 8°C. DO NOT FREEZE. A short period up to 3 months at 25°C is possible within the shelf-life period. | storage in refrigerator (+2 to +8 0C) - shelf-life: 2 years | 3 years ≤25°C | Between +2ºC and +25ºC. Do not freeze. Discard after expiration date. | |||||
| Time for reconstitution | N/A | A few minutes | none | ||||||
| Packaging* | containers with 20, 50, 100 or 200 ml | 1g, 3g, 6g, 12g | |||||||
| * May be different from country to country | |||||||||